Nob Hill Therapeutics
PrivateLast Round
Series A
Aug 6, 2024
Est. Valuation
$10M
Total Funding Raised
$6.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nob Hill Therapeutics is a biotechnology company that develops innovative pulmonary and respiratory treatments, including its proprietary DryNeb dry powder nebulizer platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nob Hill Therapeutics Comparables
Compare Nob Hill Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InhaTarget Therapeutics | 71% | |
| AptarGroup | 69% | |
| Pulmatrix, Inc. | 67% |
Nob Hill Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 6, 2024 | ||||
| Grant | Oct 3, 2023 | ||||
| Grant | Aug 23, 2022 | ||||
| Seed | Oct 31, 2016 |
Key People
Founding team and executive leadership
Nob Hill Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TCA Venture Group | Series A |
| VIC Technology Venture Development | Seed |
| Tramway Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 51% MoM to 1.8K.
- Jan 2, 2026
Monthly visitors increased 40% MoM.
Nob Hill Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nob Hill Therapeutics's valuation, stock price, and market status.
Is Nob Hill Therapeutics a public or private company?
Nob Hill Therapeutics is a private company.
What is the current stock price of Nob Hill Therapeutics?
Nob Hill Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Nob Hill Therapeutics worth (valuation)?
Nob Hill Therapeutics's valuation is estimated at $10.0M based on funding round data.
Can I buy Nob Hill Therapeutics stock?
Nob Hill Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nob Hill Therapeutics's last funding round?
Nob Hill Therapeutics's most recent funding round was Series A on August 6, 2024.
Who are the main investors in Nob Hill Therapeutics?
Key investors in Nob Hill Therapeutics include VIC Technology Venture Development, Tramway Venture Partners.
Will Nob Hill Therapeutics IPO soon?
No public IPO plans have been announced for Nob Hill Therapeutics.
How can I track Nob Hill Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nob Hill Therapeutics's secondary market activity and sign up for updates.